DJ Gilead Sciences Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Gilead Sciences Inc. (GILD) slid 1.07% to $112.54 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.47% to 6,615.28 and the Dow Jones Industrial Average rising 0.11% to 45,883.45.
This was the stock's second consecutive day of losses.
Gilead Sciences Inc. closed 7.63% below its 52-week high of $121.83, which the company reached on August 12th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 0.37% to $177.40, Pfizer Inc. $(PFE)$ rose 0.42% to $23.97, and Abbott Laboratories $(ABT)$ fell 1.79% to $131.33.
Data source: Dow Jones Market Data, FactSet. Data compiled September 15, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
September 15, 2025 16:37 ET (20:37 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.